Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Traffic & App Usage Insights

Discover domain traffic and app usage trends for companies and their competitors.

Last Close
Nov 08 04:00PM ET
121.61
Dollar change
+1.19
Percentage change
0.99
%
Index- P/E101.02 EPS (ttm)1.20 Insider Own6.13% Shs Outstand93.73M Perf Week-1.36%
Market Cap11.73B Forward P/E10.41 EPS next Y11.68 Insider Trans-0.33% Shs Float89.66M Perf Month-0.65%
Income121.84M PEG- EPS next Q1.54 Inst Own92.43% Short Float6.31% Perf Quarter-5.47%
Sales1.64B P/S7.15 EPS this Y139.82% Inst Trans5.86% Short Ratio6.17 Perf Half Y-7.75%
Book/sh12.79 P/B9.51 EPS next Y405.63% ROA3.63% Short Interest5.66M Perf Year50.71%
Cash/sh12.42 P/C9.79 EPS next 5Y- ROE12.27% 52W Range75.85 - 173.25 Perf YTD26.11%
Dividend Est.- P/FCF- EPS past 5Y-1.21% ROI4.82% 52W High-29.81% Beta0.74
Dividend TTM- Quick Ratio3.03 Sales past 5Y32.89% Gross Margin83.56% 52W Low60.33% ATR (14)4.48
Dividend Ex-Date- Current Ratio3.84 EPS Y/Y TTM116.50% Oper. Margin4.94% RSI (14)41.95 Volatility5.73% 3.23%
Employees1314 Debt/Eq1.14 Sales Y/Y TTM48.45% Profit Margin7.43% Recom1.18 Target Price192.00
Option/ShortYes / Yes LT Debt/Eq1.07 EPS Q/Q173.55% Payout- Rel Volume1.62 Prev Close120.42
Sales Surprise14.74% EPS Surprise670.47% Sales Q/Q40.79% EarningsNov 06 AMC Avg Volume916.39K Price121.61
SMA20-3.86% SMA50-3.42% SMA200-6.90% Trades Volume1,482,796 Change0.99%
Date Action Analyst Rating Change Price Target Change
Nov-07-24Upgrade Cantor Fitzgerald Neutral → Overweight $152 → $167
Oct-21-24Initiated Jefferies Buy $165
Oct-10-24Resumed Raymond James Outperform $150
Jul-29-24Upgrade RBC Capital Mkts Sector Perform → Outperform $182
Jun-26-24Downgrade Citigroup Buy → Neutral $172 → $176
May-31-24Initiated Piper Sandler Overweight $157
May-28-24Downgrade RBC Capital Mkts Outperform → Sector Perform $157 → $142
May-14-24Upgrade Oppenheimer Perform → Outperform $180
Jan-31-24Initiated BMO Capital Markets Outperform $170
Dec-13-23Resumed Citigroup Buy $113
Nov-08-24 06:57AM
Nov-07-24 06:01AM
04:00AM
02:20AM
Nov-06-24 06:30PM
04:22PM Loading…
04:22PM
04:05PM
Oct-31-24 04:10PM
Oct-27-24 09:07AM
Oct-23-24 08:30AM
Oct-18-24 08:00AM
Oct-17-24 09:53AM
Oct-16-24 04:02PM
Oct-03-24 08:15AM
Sep-30-24 04:39PM
12:38PM Loading…
12:38PM
Sep-26-24 08:30AM
Sep-21-24 10:10AM
Sep-19-24 08:30AM
Sep-16-24 08:30AM
Sep-14-24 07:27PM
Sep-13-24 06:45AM
Sep-08-24 02:00AM
Sep-06-24 11:31AM
Sep-05-24 09:00AM
Sep-03-24 12:37PM
Aug-30-24 04:10PM
08:53AM
08:30AM
Aug-20-24 02:30PM
07:00AM Loading…
Aug-19-24 07:00AM
Aug-12-24 09:30AM
Aug-09-24 04:17PM
09:35AM
Aug-08-24 01:36PM
07:50AM
12:30AM
Aug-07-24 06:00PM
04:28PM
04:17PM
04:05PM
Aug-05-24 12:00PM
Aug-01-24 10:01AM
Jul-31-24 04:15PM
Jul-29-24 07:00AM
Jul-21-24 06:59AM
Jul-19-24 09:55AM
Jul-17-24 08:00AM
Jul-16-24 12:00PM
Jul-08-24 12:04PM
Jul-06-24 08:00AM
Jul-04-24 06:35AM
Jul-03-24 10:05AM
Jun-28-24 06:30PM
Jun-26-24 10:06AM
03:45AM
Jun-24-24 02:55PM
03:49AM
Jun-21-24 05:25PM
05:05PM
04:28PM
04:23PM
02:39PM
01:53PM
01:00PM
12:58PM
12:48PM
12:29PM
12:14PM
11:24AM
11:09AM
11:00AM
10:42AM
09:32AM
09:31AM
09:14AM
08:42AM
07:52AM
07:34AM
06:40AM
Jun-20-24 05:02PM
02:13PM
01:22PM
Jun-13-24 04:04PM
01:07PM
07:00AM
Jun-06-24 07:00AM
May-31-24 05:45PM
11:31AM
May-29-24 05:48PM
08:28AM
May-28-24 10:52PM
May-24-24 11:57AM
May-23-24 07:10AM
May-17-24 08:05AM
May-14-24 07:30AM
May-04-24 12:00PM
May-03-24 10:07AM
May-02-24 03:42PM
11:30AM
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Estepan Ian MichaelChief Financial OfficerAug 30 '24Sale137.365,985822,10033,946Sep 03 08:00 PM
Estepan Ian MichaelOfficerAug 30 '24Proposed Sale137.375,985822,130Aug 30 05:03 PM
Chambers Michael AndrewDirectorAug 16 '24Buy133.8037,0384,955,728284,034Aug 20 08:00 AM
BEHRENS M KATHLEENDirectorJul 03 '24Option Exercise13.9015,000208,500191,839Jul 08 08:00 PM
Brown Ryan EdwardEVP, General CounselJun 25 '24Option Exercise62.7723,5001,475,09556,086Jun 25 08:00 PM
Brown Ryan EdwardEVP, General CounselJun 25 '24Sale161.6138,9576,296,02917,129Jun 25 08:00 PM
Arif BilalChief Tech Ops OfficerJun 24 '24Sale163.087,8591,281,62121,261Jun 25 08:00 PM
Arif BilalChief Tech Ops OfficerJun 25 '24Sale163.233,898636,27117,363Jun 25 08:00 PM
Murray DallanChief Customer OfficerMay 02 '24Sale140.003,635508,90018,125May 06 08:09 PM
Wigzell Hans Lennart RudolfDirectorMar 08 '24Option Exercise13.9015,000208,50037,840Mar 11 08:02 PM
Wigzell Hans Lennart RudolfDirectorMar 08 '24Sale123.2515,0001,848,79522,840Mar 11 08:02 PM
Boor Kathryn JeanDirectorMar 11 '24Sale122.9376193,5507,516Mar 11 08:00 PM
Mayo StephenDirectorMar 05 '24Sale122.963,135385,4806,621Mar 06 08:00 PM
Arif BilalChief Tech Ops OfficerMar 01 '24Sale128.842,000257,67626,836Mar 05 08:00 PM
Estepan Ian MichaelChief Financial OfficerMar 01 '24Sale128.301,200153,96039,114Mar 05 08:00 PM
Brown Ryan EdwardEVP, General CounselMar 01 '24Sale125.342,000250,68031,827Mar 05 08:00 PM